News
This prototype machine produces 1,000 pills in 24 hours, faster than it can take to produce some batches in a factory. Allan Myerson, a professor of chemical engineering at MIT and a leader of the effort, says it could become eventually an option for anyone who makes medications, which typically require a lengthy and complex process of crystallization.
To continue progress towards a safer healthcare system, CMS is requesting proposals for the Hospital Improvement and Innovation Networks.
AmSurg Corp.'s Physician Services Division, known as Sheridan, on Wednesday said it has acquired Jandee Anesthesiology Partners and certain assets of Karadan Anesthesiology and Pain Management.
Missouri state regulators on Wednesday said they will not support Aetna's proposed $37 billion takeover of Humana, according to documents filed May 24 by John M. Huff, director of the Department of Insurance, Financial Institutions and Professional Registration for the state.
On Tuesday, the House Ways and Means Committee passed the "Helping Hospitals Improve Patient Care Act," a bill that, among other provisions, provides financial relief for hospitals that were in the process of building off-campus outpatient centers in 2015 when the reimbursement policy was changed.
The U.S. Department of Justice on Monday filed a notice to join a whistleblower lawsuit against for-profit provider Prime Healthcare alleging it routinely submitted inpatient claims for patients who should have been treated as outpatients.
The experiment begins Wednesday at the VA's operations in Palo Alto, California. Veterans can visit 14 "MinuteClinics" operated by CVS in the San Francisco Bay area and Sacramento, where staff will treat them for conditions such as respiratory infections, order lab tests and prescribe medications, which can be filled at CVS pharmacies. Whether the partnership will spread to other VA locales isn't yet clear.
Amid a raging opioid epidemic, many doctors and families in the U.S. have been pleading for better treatment alternatives. One option now under consideration by the Food and Drug Administration is a system of implanted rods that offer controlled release of buprenorphine -- a drug already used in other forms to treat opioid addiction.
A broad proposal by Medicare to change the way it pays for some drugs has drawn intense reaction and lobbying, with much of the debate centering on whether the plan gives too much power over drug prices to government regulators.
Avalere said the cost to beneficiaries could be higher if they bought in at a younger age, mainly because Medicare offers no financial out-of-pocket cap on services.